HHS Launches Plasma and Blood Donation Campaign
On August 4, the U.S. Department of Health and Human Services (HHS) launched a new nationwide campaign, Giving=Living, intended to draw awareness to the importance of plasma and blood donation, especially following a steep decline in both caused by the Covid pandemic.
Giving=Living provides information about the role of plasma and blood in treating various medical conditions every day and utilizes stories and testimonials from patients whose lives depend on access to a range of blood products. In the case of plasma, patients facing serious and life-threatening conditions, such as primary immune deficiencies, Alpha-1 antitrypsin deficiency, hereditary angioedema, certain bleeding disorders, GBS & CIDP, and others rely on therapies that can only come from plasma donated by dedicated individuals at any of the more than 1,000 plasma donation centers across the country.
The Giving=Living campaign provides guidance about plasma donation eligibility and answers some frequently asked questions about plasma, including the donation process and how plasma is used to treat people with these rare diseases. Further, it directs visitors to PPTA’s DonatingPlasma.org site, where they can find a donation center near them and learn more about the donation process.
“PPTA appreciates our partners at HHS and in Congress for recognizing the importance of plasma as the unique starting material used in the complex manufacturing process to create plasma-derived therapies,” remarked Joshua Penrod, PPTA Senior Vice President, Head of Global Plasma. “Just as important, PPTA is grateful for the thousands of men and women who roll up their sleeves every day to give their plasma. Plasma donors save lives, and each of them deserve our praise and appreciation.”